Patents by Inventor Kevin Francis DEBOYACE

Kevin Francis DEBOYACE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID FORMS OF A CDK2 INHIBITOR
    Publication number: 20240076287
    Abstract: The invention relates to solid forms of (1R,3S)-3-[3-({[3-(methoxymethyl)-1-methyl-1H-pyrazol-5-yl]carbonyl}amino)-1H-pyrazol-5-yl]cyclopentyl propan-2-ylcarbamate, to pharmaceutical compositions comprising such solid forms, and to use of such solid forms and pharmaceutical compositions for the treatment of cancer.
    Type: Application
    Filed: December 21, 2021
    Publication date: March 7, 2024
    Applicant: PFIZER INC.
    Inventors: Fengjuan CAO, Kevin Francis DEBOYACE, Michael HEBERLEIN
  • BCKDK INHIBITORS AND/OR DEGRADERS
    Publication number: 20230167080
    Abstract: Described herein are compounds of Formula I, wherein the variables are defined herein, their use as branched-chain alpha keto acid dehydrogenase kinase inhibitors and/or degraders, pharmaceutical compositions containing such compounds and their use to treat, for example, diabetes, kidney disease, NASH and heart failure.
    Type: Application
    Filed: November 30, 2022
    Publication date: June 1, 2023
    Applicant: Pfizer Inc.
    Inventors: Leanne Marie BUZON, Kimberly O'Keefe CAMERON, Kevin Francis DEBOYACE, Kevin James FILIPSKI, David Andrew GRIFFITH, Bethany Lyn KORMOS, Shenping LIU, Luis Angel MARTINEZ ALSINA, Matthew Richard REESE, Rachel Jane ROTH FLACH, Yuan ZHANG